|
USO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32119999998837E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.93920000349735E-08 |
| Normal-vs-Stage2 |
1.789760E-01 |
| Normal-vs-Stage3 |
3.790200E-02 |
| Normal-vs-Stage4 |
5.630200E-01 |
| Stage1-vs-Stage2 |
1.518780E-01 |
| Stage1-vs-Stage3 |
2.689800E-01 |
| Stage1-vs-Stage4 |
1.476590E-01 |
| Stage2-vs-Stage3 |
6.810400E-01 |
| Stage2-vs-Stage4 |
7.294600E-01 |
| Stage3-vs-Stage4 |
4.910800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.94549999963523E-07 |
| Normal-vs-AfricanAmerican |
7.352000E-04 |
| Normal-vs-Asian |
1.141540E-02 |
| Caucasian-vs-AfricanAmerican |
8.676800E-01 |
| Caucasian-vs-Asian |
9.760200E-01 |
| AfricanAmerican-vs-Asian |
9.255800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08700001724793E-09 |
| Normal-vs-Female |
2.112400E-01 |
| Male-vs-Female |
4.612100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.962400E-03 |
| Normal-vs-Extreme_Weight |
3.88449999944029E-08 |
| Normal-vs-Obese |
1.435850E-02 |
| Normal-vs-Extreme_Obese |
5.828400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.053000E-01 |
| Normal_Weight-vs-Obese |
5.356200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.653200E-01 |
| Extreme_Weight-vs-Obese |
3.133800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.791600E-01 |
| Obese-vs-Extreme_Obese |
4.984200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.418200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.580500E-04 |
| Normal-vs-Age(61-80Yrs) |
6.52889999841477E-08 |
| Normal-vs-Age(81-100Yrs) |
9.783600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.005000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.625700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.482200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.443800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.339850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.244200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.1019997681625E-10 |
| Normal-VS-Type2 PRCC |
4.435500E-03 |
| Normal-VS-KIRP CIMP |
7.081400E-01 |
| Normal-VS-Unclassified PRCC |
1.465450E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.128400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.236200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.684160E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.166750E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.470000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.720800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74089999996452E-06 |
| Normal-vs-N1 |
4.955800E-01 |
| Normal-vs-N2 |
3.246800E-01 |
| N0-vs-N1 |
1.787550E-02 |
| N0-vs-N2 |
8.102200E-01 |
| N1-vs-N2 |
4.241400E-01 |
|
|
